Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucie Canaff

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Scientific Reports|December 14, 2022
Author Correction: Transforming Growth Factor-beta Regulation of Ephrin Type-A Receptor 4 Signaling in Breast Cancer Cellular MigrationIbrahim Y Hachim, Manuel Villatoro, Lucie Canaff, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 30, 2011
Parathyroid hormone signaling via Gαs is selectively inhibited by an NH(2)-terminally truncated Gαs: implications for pseudohypoparathyroidismSvetlana Puzhko, Cynthia Gates Goodyer, Mohammad Amin Kerachian, et al.
The Journal of Biological Chemistry|March 22, 2003
Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineageHideaki Sowa, Hiroshi Kaji, Lucie Canaff, et al.
Scientific Reports|November 22, 2025
Translational readthrough therapy for ADPKD induces polycystin1 expression and partially rescues functional deficits in PKD1 mutant cellsElena Torban, Lucie Canaff, Sima Babayeva, et al.
The Journal of Biological Chemistry|January 18, 2011
Parathyroid hormone-responsive Smad3-related factor, Tmem119, promotes osteoblast differentiation and interacts with the bone morphogenetic protein-Runx2 pathwayItoko Hisa, Yoshifumi Inoue, Geoffrey N Hendy, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Recurrent familial hypocalcemia due to germline mosaicism for an activating mutation of the calcium-sensing receptor geneGeoffrey N Hendy, Carla Minutti, Lucie Canaff, et al.
Cells|June 19, 2024
Multiple Endocrine Neoplasia Type 1 Regulates TGFβ-Mediated Suppression of Tumor Formation and Metastasis in MelanomaJulien Boudreault, Lucie Canaff, Mostafa Ghozlan, et al.
Bone|May 15, 2012
Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cellsKen-ichiro Tanaka, Yoshifumi Inoue, Geoffrey N Hendy, et al.
Molecular Endocrinology (Baltimore, Md.)|March 20, 2004
Activin inhibits pituitary prolactin expression and cell growth through Smads, Pit-1 and meninAnnie Lacerte, Eun-Hye Lee, Rachel Reynaud, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2006
A hypocalcemic child with a novel activating mutation of the calcium-sensing receptor gene: successful treatment with recombinant human parathyroid hormoneSteven D Mittelman, Geoffrey N Hendy, Richard A Fefferman, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Scientific Reports|December 14, 2022
Author Correction: Transforming Growth Factor-beta Regulation of Ephrin Type-A Receptor 4 Signaling in Breast Cancer Cellular MigrationIbrahim Y Hachim, Manuel Villatoro, Lucie Canaff, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 30, 2011
Parathyroid hormone signaling via Gαs is selectively inhibited by an NH(2)-terminally truncated Gαs: implications for pseudohypoparathyroidismSvetlana Puzhko, Cynthia Gates Goodyer, Mohammad Amin Kerachian, et al.
The Journal of Biological Chemistry|March 22, 2003
Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineageHideaki Sowa, Hiroshi Kaji, Lucie Canaff, et al.
Scientific Reports|November 22, 2025
Translational readthrough therapy for ADPKD induces polycystin1 expression and partially rescues functional deficits in PKD1 mutant cellsElena Torban, Lucie Canaff, Sima Babayeva, et al.
The Journal of Biological Chemistry|January 18, 2011
Parathyroid hormone-responsive Smad3-related factor, Tmem119, promotes osteoblast differentiation and interacts with the bone morphogenetic protein-Runx2 pathwayItoko Hisa, Yoshifumi Inoue, Geoffrey N Hendy, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Recurrent familial hypocalcemia due to germline mosaicism for an activating mutation of the calcium-sensing receptor geneGeoffrey N Hendy, Carla Minutti, Lucie Canaff, et al.
Cells|June 19, 2024
Multiple Endocrine Neoplasia Type 1 Regulates TGFβ-Mediated Suppression of Tumor Formation and Metastasis in MelanomaJulien Boudreault, Lucie Canaff, Mostafa Ghozlan, et al.
Bone|May 15, 2012
Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cellsKen-ichiro Tanaka, Yoshifumi Inoue, Geoffrey N Hendy, et al.
Molecular Endocrinology (Baltimore, Md.)|March 20, 2004
Activin inhibits pituitary prolactin expression and cell growth through Smads, Pit-1 and meninAnnie Lacerte, Eun-Hye Lee, Rachel Reynaud, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2006
A hypocalcemic child with a novel activating mutation of the calcium-sensing receptor gene: successful treatment with recombinant human parathyroid hormoneSteven D Mittelman, Geoffrey N Hendy, Richard A Fefferman, et al.
Pageof 6